The cytotoxic effect of activated T cells was also evaluated using co-cultivation of tumor organoids and engineered T cells targeting MUC1, an antigen highly expressed in both primary tumors and their derived organoids [41]. This evidence concerns the gene MUC1 and neoplasm.